Resveratrol modulates Toxoplasma gondii infection induced liver injury by intervening in the HMGB1/TLR4/NF-κB signaling pathway

Metformin Attenuates Ischemia-reperfusion Injury of Fatty Liver in Rats Through Inhibition of the TLR4/NF-κB Axis

(2021) Xiaohua Li et al.   Balkan Medical Journal

Arctigenin ameliorates depression-like behaviors in Toxoplasma gondii-infected intermediate hosts via the TLR4/NF-κB and TNFR1/NF-κB signaling pathways

(2020) Jia-Hui Cheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Isochlorogenic Acid A Attenuates the Progression of Liver Fibrosis Through Regulating HMGB1/TLR4/NF-κB Signaling Pathway

(2020) Xin Liu et al.   Frontiers in Pharmacology

Antidepressive Effect of Arctiin by Attenuating Neuroinflammation via HMGB1/TLR4- and TNF-α/TNFR1-Mediated NF-κB Activation

(2020) Xiang Xu et al.   ACS Chemical Neuroscience

Arctigenin exhibits hepatoprotective activity in Toxoplasma gondii-infected host through HMGB1/TLR4/NF-κB pathway

(2020) Yu-Nan Lu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF‐κB and TNF‐α/TNFR1/NF‐κB pathways

(2020) Xiang Xu et al.   BRITISH JOURNAL OF PHARMACOLOGY

HMGB1 Inhibits HNF1A to Modulate Liver Fibrogenesis via p65/miR-146b Signaling

(2020) Shanfei Ge et al.   DNA AND CELL BIOLOGY

Ginsenoside Rh2 attenuates microglial activation against toxoplasmic encephalitis via TLR4/NF-κB signaling pathway

(2019) Xiang Xu et al.   Journal of Ginseng Research

Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling

(2019) Yam Nath Paudel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Protective Effects of Fucoxanthin against Alcoholic Liver Injury by Activation of Nrf2-Mediated Antioxidant Defense and Inhibition of TLR4-Mediated Inflammation

(2019) Jiawen Zheng et al.   Marine Drugs

Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice

(2019) Xujie Jiang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening

(2019) Yu Deng et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights

(2018) Diego de Sá Coutinho et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Congenital toxoplasmosis: An overview of the neurological and ocular manifestations

(2018) Wajihullah Khan et al.   PARASITOLOGY INTERNATIONAL

Toxoplasma gondii

(2018) Joshua A. Kochanowsky et al.   CURRENT BIOLOGY

The direct and indirect inhibition effects of resveratrol against Toxoplasma gondii tachyzoites in vitro

(2018) Qi-Wei Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease?- a population-based study

(2018) Jiaofeng Huang et al.   BMC INFECTIOUS DISEASES

Could Araucaria heterophylla resin extract be used as a new treatment for toxoplasmosis?

(2018) Nora L. El-Tantawy et al.   EXPERIMENTAL PARASITOLOGY

Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis

(2018) Chongshan Dai et al.   Cell Death & Disease

Drug Resistance in Toxoplasma gondii

(2018) Mahbobeh Montazeri et al.   Frontiers in Microbiology

The polysaccharide from Inonotus obliquus protects mice from Toxoplasma gondii-induced liver injury

(2018) Lu Xu et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-α-induced inflammation in microglia cells

(2018) Ying Lu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The Role of Resveratrol in Cancer Therapy

(2017) Jeong-Hyeon Ko et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Observations on bradyzoite biology

(2017) Vincent Tu et al.   MICROBES AND INFECTION

Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cells

(2017) Zhi Hong Zhang et al.   PHYTOTHERAPY RESEARCH

Drugs in development for toxoplasmosis: advances, challenges, and current status

(2017) Holland Alday et al.   Drug Design Development and Therapy

Antioxidant effects of resveratrol in the cardiovascular system

(2016) Ning Xia et al.   BRITISH JOURNAL OF PHARMACOLOGY

Trillin Reduces Liver Chronic Inflammation and Fibrosis in Carbon Tetrachloride (CCl4) Induced Liver Injury in Mice

(2016) Huabing Tan et al.   IMMUNOLOGICAL INVESTIGATIONS

Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo

(2016) Diao He et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway

(2016) XUEQIANG JIANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Synergistic effects of resveratrol (free and inclusion complex) and sulfamethoxazole-trimetropim treatment on pathology, oxidant/antioxidant status and behavior of mice infected with Toxoplasma gondii

(2016) Nathieli B. Bottari et al.   MICROBIAL PATHOGENESIS

The molecular targets of resveratrol

(2015) Sameer S. Kulkarni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Pathological changes in acute experimental toxoplasmosis with Toxoplasma gondii strains obtained from human cases of congenital disease

(2015) Breno Veloso Pinheiro et al.   EXPERIMENTAL PARASITOLOGY

Severe Toxoplasmic Hepatitis in an Immunocompetent Patient

(2015) Aynur ATİLLA et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Nitric oxide in liver diseases

(2015) Yasuko Iwakiri et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii

(2014) Yanhua Wang et al.   Parasites & Vectors

Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden

(2012) Yinon Shapira et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine

(2011) H. Khalili et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection

(2011) Ulf Andersson et al.   Annual Review of Immunology

The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer

(2011) Christian Liedtke et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation

(2010) Stefan Bereswill et al.   PLoS One

Targeting HMGB1 in inflammation

(2009) Huan Yang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis

(2009) Georgios Pappas et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Resveratrol bioavailability and toxicity in humans

(2009) Charles-Henry Cottart et al.   MOLECULAR NUTRITION & FOOD RESEARCH

The IKK Complex, a Central Regulator of NF- B Activation

(2009) A. Israel   Cold Spring Harbor Perspectives in Biology